Life Sciences & Healthcare

Title here

Text here

2022 Global Life Sciences Outlook Digitalization at scale: Delivering on the promise of science

While valuations for the life sciences sector in this past year have been mixed, the underlying performance and outlook for the sector is healthy. We saw many companies’ growth buoyed by COVID-19 therapeutics, and the majority of others remaining fairly immune to some of the pandemic impacts initially feared (e.g., slowdown in patient recruitment and trial execution). We anticipate further growth in the industry as life sciences companies continue to transform.

Five ways that life science companies can build tech talent

For life science companies to meet their digital ambitions, they must strengthen their technology skills. In a challenging market, the industry is uniquely positioned to shine.

The Digital Innovations Behind The Booming Life Sciences Industry

Life sciences industry manufacturers are digitalizing business to deliver more personalized services and head off supply chain disruptions, while reducing costs and innovating for the future. IDC analysts predicted that by 2023, 75% of life science manufacturers will invest in intelligent supply chain solutions to enable resilience and prevent future disruptions in health emergencies such as COVID-19.

The convergence of the technology and healthcare sectors

The following is a summary of a moderated discussion with KPMG’s Mark Gibson (national sector leader, Technology, Media & Telecommunications) and Ash Shehata (national sector leader, Healthcare & Life Sciences). The conversation covered the impact of technology, NFT’s, cyber security, and talent on the healthcare sector.

Enter your details to download eBook

Download eBook